AbbVie (NYSE:ABBV) Releases Q4 2024 Earnings Guidance

AbbVie (NYSE:ABBV – Get Free Report) updated its fourth quarter 2024 earnings guidance on Monday. The company provided earnings per share guidance of 2.060-2.100 for the period, compared to the consensus earnings per share estimate of 2.980. The company issued revenue guidance of -. AbbVie also updated its FY 2024 guidance to 10.020-10.060 EPS. AbbVie […]

Leave a Reply

Your email address will not be published.

Previous post Omineca Mining and Metals (CVE:OMM) Stock Price Up 25% – Here’s Why
Next post Canandaigua National Bank & Trust Co. Cuts Stock Holdings in PepsiCo, Inc. (NASDAQ:PEP)